Meridian Bioscience (VIVO) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $33.97 --0%
EPS Growth %: -100.0%
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
EPS Growth %: -100.0%
Financial Fact:
Research and development: 3.76M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $51.3 million versus the consensus estimate of $52.1 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Bunge Limited (BG) Tops Q1 EPS by 50c, misses on revenue and guidance
- Biogen (BIIB) Tops Q1 EPS by 24c; reaffirms guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
